477
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A new fluorescenttargeting tracer contrasts dual tracers in sentinel lymph node biopsy of breast cancer

ORCID Icon, , , , &
Pages 951-958 | Received 11 Sep 2022, Accepted 28 Feb 2023, Published online: 29 Nov 2023

References

  • Giuliano AE , BallmanKV , McCallLet al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA318(10), 918–926 (2017).
  • Galimberti V , ColeBF , VialeGet al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol.19(10), 1385–1393 (2018).
  • Grasishar WJ , AndrsonBO , BalassanianRet al. Breast Cancer, Version 4. 2020 Featured Updates to the NCCN Guidelines. National Comprehensive Cancer Network, BINV-D (2020). www.NCCN.org
  • Lucci A , McCallLM , BeitschPDet al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J. Clin. Oncol.25(24), 3657–3663 (2007).
  • Pitsinis V , ProvenzanoE , KaklamanisLet al. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer. Surg. Oncol.24, 375–379 (2015).
  • Shen S , XuQ , ZhouYet al. Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer. J. Surg. Oncol.117(8), 1841–1847 (2018).
  • Cong BB , SunX , SongXRet al. Preparation study of indocyanine green–rituximab: a new receptor-targeted tracer for sentinel lymph node in breast cancer. Oncotarget7(30), 47526–47535 (2016).
  • Tian C , SunX , CongBet al. Murine model study of a new receptor-targeted tracer for sentinel lymph node in breast cancer. J. Breast Cancer22(2), 274–284 (2019).
  • Ahmed M , PurushothamAD. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol.15, 351–362 (2014).
  • Sugie T , SawadaT , TagayaNet al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann. Surg. Oncol.20(7), 2213–2218 (2013).
  • Kameswaran M , SubramanianS , PandeyUet al. Preliminary evaluation of the potential of 99mTc carbonyl-DTPA-rituximab as a tracer for sentinel lymph node detection. Appl. RadiatIsot.107, 195–198 (2016).
  • Dias CR , JegerS , OssoJAet al. Radiolabeling of rituximab with (188) Re and (99m) Tc using the tricarbonyl technology. Nucl. Med. Biol.38(1), 19–28 (2011).
  • Hope-Ross M , YannuzziLA , GragoudasESet al. Adverse reactions due to indocyanine green. Ophthalmology101(3), 529–533 (1994).
  • Sugie T , IkedaT , KawaguchiAet al. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis. Int. J. Clin. Oncol.22(1), 11–17 (2017).
  • Mazouni C , KoualM , DeLeeuw Fet al. Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer. Breast J.24(6), 1006–1009 (2018).
  • Kim H . Multimodal photoacoustic imaging as a tool for sentinel lymph node identification and biopsy guidance. Biomed. Eng. Lett.8(2), 183–191 (2018).